Innovation in an already crowded oncology space has created a challenge for medical affairs. The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the scientific need of experts, while continuously demonstrating value. To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to leverage this information to inform targeted decisions and investments.
Vice President - Global Medical Strategy
Senior Director, Business Partnerships